Skip to content

Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia

Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02242526
Enrollment
312
Registered
2014-09-17
Start date
2014-09-30
Completion date
2020-08-31
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiatal Hernia

Keywords

hiatal hernia, recurrence, biologic mesh, synthetic mesh

Brief summary

The investigators propose a randomized, single blinded controlled trial to compare the use of synthetic versus biologic mesh in hiatal hernia repair, two currently accepted standard of care surgical modalities. The investigators hypothesize that use of synthetic mesh will have lower recurrence at these time points compared to use of biologic mesh.

Detailed description

Patients will be randomized to either a synthetic (light weight synthetic or biologic (small intestinal submucosa ) mesh group. Endpoints will be measured up to 5 years for the study as a whole, at 6 months and at 60 months. Prior to and following laparoscopic paraesophageal hernia repair, patients will be followed with both subjective and objective measures. Subjective evaluation will include symptomatic/quality of life assessment at 1-, 6-, 24-, and 60- month periods; objective evaluation will include Upper GI study /pH probe study for symptomatic patients and for all patients at 6 and 60 months. The investigators hypothesize that use of synthetic mesh will have lower recurrence at these time points compared to use of biologic mesh.

Interventions

DEVICEParietex™ Composite Hiatal Mesh, North Haven, CT

Parietex™ Composite Hiatal Mesh (North Haven, CT) designed for hiatal hernia repair.

DEVICEBiodesign™ Surgisis® Graft, Cook Medical, Bloomington

Biodesign™ Surgisis® Graft (Cook Medical, Bloomington) designed for hiatal hernia repair.

Sponsors

Stony Brook University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female gender * Age\>18 years * Absence of chronic medical conditions that will affect the quality of life survey, such as fibromyalgia, SLE, Crohn's disease, etc. * Able to give informed consent * Able and willing to participate in follow-up evaluations * Upper GI with a documented hiatal hernia greater than 5cm * Paraesophageal hernia with clinically relevant symptoms such as heartburn, chest pain, regurgitation, dysphagia, postprandial abdominal pain, shortness of breath, or early satiety.

Exclusion criteria

* Previous surgery of the esophagus and/or the stomach * Emergent operation for acute gastric volvulus or strangulation * Biopsy consistent with malignancy * Body Mass Index (BMI) over 35kg/m2 * Inability to perform primary closure of crura * Active smoking

Design outcomes

Primary

MeasureTime frameDescription
Assess for reappearance of hiatal hernia and reflux6 months, 60 monthsChange at 6 and 60 months will be assessed by pH and Upper GI (endoscopy) studies to assess for reappearance of hiatal hernia and reflux.

Secondary

MeasureTime frameDescription
Quality of Life questionnaireQuality of Life will be assessed at these time periods after the hernia repair 1, 6, 24, and 60 monthsQuality of life questionnaire containing 36 questions

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026